No qualifying author-owned investment thesis was confirmed in this post.
no investment thesis
Comments10
▶ Full Post Text
Can someone explain how McKesson (MCK), a pharma distribution and logistics company with some care delivery arms, is trading at a higher earnings multiple than Microsoft (MSFT)?
It’s even trading at a higher multiple than its core customers (Pfizer, Merck, Novartis, Novo).